Journal article
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.
Abstract
Authors
Chagla Z
Journal
Annals of Internal Medicine, Vol. 174, No. 2,
Publisher
American College of Physicians
Publication Date
February 1, 2021
DOI
10.7326/acpj202102160-015
ISSN
1056-8751